Gardasil/Gardasil 9 Disease area(s): Vaccines/infectious diseases Manufacturer(s): Merck 2024 Sales (USD): $8.58 billion Why it sold so well: In 2024, Mercks Gardasil/Gardasil 9 vaccine generated $8.58 billion in global sales, marking a 3% decline from the previous year, primarily due to reduced demand in China
Maintain a clean, designated area for medication preparation away from food preparation surfaces
Standard servings are unlikely to cause typical acne, and evidence against iodide as a comedonal trigger is strong
38% of GLP-1 users say they may switch to an alternative like Compounded* Liraglutide with B12 soon
The LS findings add another piece to this puzzle, offering some initial clues about a neural substrate where dual incretin receptor signaling might exert these effects
The FDA approach to GLP-1 compounding will set precedents that affect access to peptide therapy across many categories